BridgeBio Oncology Therapeutics, Inc. (BBOT) Debt Components
- 2026-03-31: Notes Payable, CurrentUSD (m); Notes PayableUSD (m); Debt Instrument, Convertible, Conversion Ratiopure 3 month · 8.89%; Debt Instrument, Redemption Price, Percentagepure 3 month · 8.00%.
- 2026-03-31: Notes Payable, CurrentUSD $716.00K; Notes PayableUSD (m); Debt Instrument, Convertible, Conversion Ratiopure (m); Debt Instrument, Redemption Price, Percentagepure (m).
- 2025-12-31: Notes Payable, CurrentUSD $534.00K; Notes PayableUSD (m); Debt Instrument, Convertible, Conversion Ratiopure (m); Debt Instrument, Redemption Price, Percentagepure (m).
- 2025-12-31: Notes Payable, CurrentUSD (m); Notes PayableUSD (m); Debt Instrument, Convertible, Conversion Ratiopure 12 month · 8.89%; Debt Instrument, Redemption Price, Percentagepure 12 month · 8.00%.
BridgeBio Oncology Therapeutics, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable, Current USD | Notes Payable USD | Debt Instrument, Convertible, Conversion Ratio pure | Debt Instrument, Redemption Price, Percentage pure |
|---|---|---|---|---|
| 2026-03-31 | (m) | (m) | 3 month · 8.89% | 3 month · 8.00% |
| 2026-03-31 | $716.00K | (m) | (m) | (m) |
| 2025-12-31 | $534.00K | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | 12 month · 8.89% | 12 month · 8.00% |
| 2025-09-30 | (m) | (m) | 9 month · 8.89% | (m) |
| 2025-09-30 | $691.00K | (m) | (m) | (m) |
| 2025-08-31 | (m) | (m) | (m) | 1 month · 8.00% |
| 2025-08-11 | (m) | (m) | 8.89% | (m) |
| 2024-12-31 | $483.00K | (m) | (m) | (m) |
| 2023-12-31 | $70.09K | (m) | (m) | (m) |
| 2021-06-19 | (m) | $300.00K | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |